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Perinatal asphyxia is a common cause of morbidity and mortality in the newborn and is associated with
myocardial injury in a signiﬁcant proportion of cases. Biomarkers, echocardiography, and rhythm dis-
turbances are sensitive indicators of myocardial ischemia and may predict mortality. We present a case of
severe myocardial dysfunction immediately after delivery managed with extracorporeal membrane
oxygenation (ECMO) and discuss the role of cardiac biomarkers, echocardiography, electrocardiography,
and ECMO in the asphyxiated newborn.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Perinatal asphyxia is a common cause of morbidity and mor-
tality in the newborn period with an incidence between 0.5 and 2%
[1,2]. The newborn myocardium is preferentially spared during the
early phase of newborn hypoxemia; however, evidence of
myocardial injury is present in 29e78% of newborns diagnosed
with hypoxic-ischemic encephalopathy (HIE) [3e5]. Global oxygen
deprivation, which is suggested by a 5 min Apgar score less than 7,
underlies the pathogenesis of myocardial injury in the newborn
period [6,7]. Additionally, biomarkers of myocardial injury (i.e.
troponin and CK-MB), echocardiographic abnormalities, and
rhythm disturbances are sensitive indicators of myocardial
ischemia and may predict mortality [7]. We present a case of an
infant who developed severe myocardial dysfunction following
emergent Caesarian delivery for fetal decelarations and was
managed with extracorporeal membrane oxygenation (ECMO). We
discuss the role of cardiac biomarkers, echocardiography, electro-
cardiography (ECG), and ECMO in the asphyxiated newborn.1. Case presentation
A 22-year-old G1P0 mother presented to a regional hospital with
symptoms of labor at 35 weeks gestation. The perinatal history wasGeorgia Regents University,
1 706 721 2331; fax: þ1 706
d).
c. This is an open access article undesigniﬁcant for insulin-dependent diabetes mellitus and chronic
hypertension. A normal anatomic ultrasound was noted, however
fetal echocardiographywas not performed. Following a trial of labor
and poor progression, late decelerations were noted and the infant
was delivered by Caesarian section. Upon delivery, the 2,700 g in-
fant appeared ﬂoppy without spontaneous respiratory effort and
persistent bradycardia. Resuscitative efforts in the delivery room
included intubation, ventilation, chest compressions (15 min),
multiple ﬂuid boluses, and epinephrine. APGAR scores were 1, 3,
and 5 at 1, 5, and 10 min, respectively and an initial arterial blood
gas provided evidence of severe metabolic acidosis with a pH of
6.81 and base deﬁcit of 23. The patient was transferred to the
in-hospital Level III NICU and was noted to have spontaneous res-
pirations and movement with signiﬁcant hypoxemia (70e80% sat-
urations on FiO2 of 1.0). However, the patient experienced
prolonged bradycardia (60e70 b.p.m.) and a corresponding rhythm
strip revealed ST segment elevation. A continuous infusion of
epinephrine was initiated and the infant was transferred to our
institution for further care at 2 h of life.
Active whole-body cooling was initiated on arrival to our NICU.
A chest X-ray following admission revealed a normal cardiac
silhouette and mild interstitial markings and echocardiography
demonstrated a thickened interventricular septum, left ventricular
ejection fraction of 21% and severe pulmonary hypertension. A
continuous infusion of milrinone at 0.5 mcg/kg/min was initiated
and multiple ﬂuid boluses and inotropic support with dopamine
and dobutamine were necessary for adequate perfusion. Epineph-
rine was discontinued following stabilization of blood pressure andr the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Troponin I levels (ng/dl) over the ﬁrst 10 days of life. Initial value was 62 ng/mL
(normal 0.02e0.06 ng/mL).
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and high frequency oscillatory ventilation was 7.1/57/28/17/-13. An
initial lactic acid was measured at 11.2 mmol/L and troponin I was
measured at 62 ng/mL (normal 0.02e0.06 ng/mL). Inhaled nitric
oxide therapy was initiated for persistent pulmonary hypertension
with minimal improvement in blood oxygen content. Acceptable
perfusion and blood pressure were obtained and maintained with
inotropic support. The infant was placed on veno-venous (VV)
ECMO at 10 h of life. The collaborative decision to place the infant
on VV ECMO was based on recent center-speciﬁc experience of
patients with cardiomyopathy, which demonstrates that these pa-
tients can be effectively supported on VV ECMO with continued
inotropic support. Recently, we successfully supported two infants
of diabetic mothers with cardiomyopathy on VV ECMO and were
discharged home. Our decision included a plan to convert to VA
ECMO if necessary. The ability to wean inotropes can be used as an
indirect marker of improved cardiac function and, in fact, dopamineTable 1
Summary of EKG, ECHO, and cardiac biomarkers for patients with perinatal myocardial i
Year Author Arrest EKG Ech
2014 Ham Yes Diffuse ST elevation EF
thic
biv
2014 Deutsch No ST elevation in the anterior
leads and ST depression in
the inferior leads.
EF
wa
reg
2012 Farooqi No Q-waves in Leads I and II,
with ST segment changes
in the precordial leads
EF
2009 Ferns Yes Q waves and ST elevation
in lateral leads, T wave
inversion in leads V4eV6,
and poor R wave progression
with ST depression in V1eV4.
Sev
and
2009 Ferns No Anterolateral myocardialinfarction Fra
atri
and
2009 Ferns No Anterolateral Q wave myocardial
infarction
Dila
and
1997 Saker No Q waves in leads I, V5, and V6 Fra
AV
wa
1996 Tometski No ST elevation in V4eV6 Fra
wa
History of cardiac arrest, EKG and ECHO ﬁndings as well as serum cardiac enzymes areand dobutamine were weaned and discontinued at 48 h of life and
milrinone was continued for afterload reduction.
Corresponding with the patient’s ability to wean inotropes,
serum tropoinin and lactic acid levels improved (Fig. 1). Serial
ECHOs failed to demonstrate improvement in cardiac function
(EFw20%); however, the infant was clinically stable with improved
acid/base balance and adequate oxygenation. On DOL 7, infant was
weaned to 30% oxygen and 0.4 L/min of sweep gas via ECMO with
improved oxygenation and ventilation. On DOL 9, the infant dete-
riorated rapidly and an ECHO demonstrated absent right ventric-
ular function and cor pulmonale. Following discussion about
prognosis with the family, the parents elected to withdraw ECMO
and ventilator support. The infant expired following discontinua-
tion of ECMO.2. Discussion
The etiologic event leading to myocardial failure in our patient
was likely perinatal asphyxia resulting in global hypoxia and car-
diac ischemia, which was superimposed on predisposing maternal
risk factors including diabetes mellitus. Other common etiologies of
sudden myocardial failure in the newborn period include para-
doxical coronary embolism, thrombosis, enteroviral myocarditis,
erythroblastosis fetalis, and congenital cardiac anomalies [8]. The
diagnosis of myocardial failure with associated pulmonary hyper-
tension secondary to perinatal asphyxia was suggested by patient
history, ECG, echocardiography, and biomarkers.
ECG abnormalities suggestive of ischemia have been noted in
19% of neonates with asphyxia [3], but are only reliable after the
ﬁrst 24 h of life [9]. Jedeiken et al. proposed a 4-stage grading
system of myocardial ischemia based on a comprehensive assess-
ment of ECGs from “at risk” infants [9]. Validation studies of the
grading system suggested that infants with ECGs meeting criteria
for grade 3 and 4 corresponded with evidence of myocardial
ischemia and were associated with higher mortality in the setting
of perinatal asphyxia [2,7,10]. Our patient’s initial ECG revealed
diffuse ST segment elevation suggestive of global ischemiaschemia who were managed with ECMO.
ocardiogram Cardiac biomarkers
21%, severe pulmonary hypertension,
kened interventricular septum, poor
entricular function
Troponin I 62.45 ng/mL
27%. Anterolateral, apical, and inferior
ll akinesis. Moderate AV valve
urgitation
Troponin T 24.72 ng/mL
43% and left ventricular wall motion abnormalities Troponin I 2.73 ng/mL
ere supravalvularaortic obstruction
extremely poor biventricularfunction
Troponin T 1.9 ng/mL
ctional shortening of 15%, dilated left
um, impaired LV posterior wall function,
severe mitral regurgitation
Troponin T 0.3 ng/mL
ted left ventricle with marked septal
posterior wall dyskinesia
Troponin T 10.5 ng/mL
ctional shortening 21%, Poor function,
valve regurgitation, PDA, no regional
ll motion abnormalities.
CK 4478 U/L
CK-MB 4 U/L
CPK 4478 U/L
LDH 2043 U/L
ctional shortening 22%, left ventricular
ll and apex akinesis.
CK ¼ 663 IU/L
listed.
Table 2
Summary of case reports for all patients with perinatal myocardial ischemia who were managed with ECMO.
Author Cardiac lesion Cardiac catheterization ECMO type Time (days) Survival Follow up/notes
Ham Global dysfunction No VV 9 No Persistent right heart failure resulting
in withdrawal of care
Deutsch Occlusion of LAD coronary artery Yes. Intracoronary r-tPA VA 7 Yes Normal ECHO at 4 months.
Farooqi Ramus intermediusartery occlusion Yes NR 5 Yes Normal ECHO at 1 year
Ferns Aortic thrombus with occlusion of
left coronary artery ostium.
No. Surgical thrombectomy performed VA 4 Yes Persistent left ventricular dysfunction
and mitral regurgitation at 5 years.
Ferns Mitral regurgitation No. Mitral valve repair and annuloplasty NR 7 Yes Improved cardiac function at 3 years
Ferns Mitral regurgitation No. Attempted mitral valve repair VA 15 No Left ventricular infarction noted during
mitral valve repair
Saker Global dysfunction Yes. Attenuated arborization of both
coronary arteries
NR 8 Yes Normal ECHO and neurodevelopment
at 22 months.
Tometski Global dysfunction Yes. Normal coronary anatomy VA 10 þ 5 Yes Required mitral valve replacement.
Cardiac lesion, results of cardiac catheterization if performed, ECMO type, ECMO run time, survival, and follow up data are presented.
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reported 100% mortality in four patients with grade 4 changes [7].
Echocardiography is a valuable assessment tool in perinatal
asphyxia and often reveals depressed left ventricular function,
which is associated with a poor prognosis [7]. Signiﬁcant differ-
ences between survivors and non-survivors of perinatal asphyxia
have been noted in ejection fraction (56% vs. 43%), fractional
shortening (28.8 vs. 21.4), and tricuspid regurgitation (2þ) (11.9%
vs. 76%) [11]. Our patient’s ejection fraction (21%) and tricuspid
regurgitation suggests a high risk of mortality.
Cardiac biomarkers may improve the diagnosis of myocardial
injury, help guide management, and estimate mortality risk
following neonatal hypoxic-ischemia [12]. While CK [7], CK-MB
[1,2,7,10], Troponin T [1,13], and Troponin I have all been studied,
Troponin I appears to have the highest predictive value [2,10,11,14].
Multiple studies suggest that serum troponin I should be done at
the onset of a hypoxic-ischemic insult and, if initially elevated,
measured serially for the ﬁrst three days [10,12,14]. Troponin I ap-
pears to be the most sensitive biochemical marker of myocardial
ischemia in the prediction of early mortality following perinatal
asphyxia and suggested a cutoff value of 0.135 ng/mL (sensitivity
0.85; speciﬁcity 0.69; p < 0.0001) for lethal outcome [11]. Our
patient’s serum troponin I values were orders of magnitude higher
than this suggested cutoff value [11].
Extracorporeal membrane oxygenation (ECMO) has been used
in the setting of neonatal myocardial ischemia previously [8,15e19].
However, the majority of case reports and series of neonatal
myocardial ischemia are the result of abnormal coronary artery
anatomy or coronary artery occlusion resulting in myocardial
infarction. Our patient experienced multi-organ system dysfunc-
tion, which is more consistent with hypoxic-ischemic encepha-
lopathy. An ethical question raised by our case is whether or not
extremely elevated serum troponin I levels and echocardiographic
evidence of severe myocardial dysfunction should be a contrain-
dication to ECMO and suggest palliative care. Any one or grouping
of these predictive models requires further external validation as
multiple groups have reported intact survival in patients under-
going ECMO following perinatal asphyxia and myocardial ischemia.
A summary of these studies is presented in Tables 1 and 2 [8,15e19].
Complete recovery from large and severe myocardial infarctions
occurred in a remarkable number of cases [8,15,17,20], which sug-
gests that ECMO may provide myocardial support and promote
recovery in non-infarcted areas. Mortality in a single case report
was associated with a serum Troponin I of 10.5 ng/mL [19], while an
intact survivor supported with ECMO had an initial serum troponin
value of 24.72 ng/mL [8]. The predictive value of serum troponin I as
contraindication for ECMO remains unclear. While we have suc-
cessfully utilized VV ECMO for the treatment of profound cardio-
myopathy, the need for epinephrine for heart rate and bloodpressure support coupled with the extreme elevation in myocardial
biomarkers makes the decision to use VV ECMO in this patient
controversial. It is our belief that many of these patients beneﬁt
from ventricular ﬁlling and “forward ﬂow” through the coronary
arteries, which is unique to VV ECMO; however, threshold values
for VA ECMO should be given strong consideration.
3. Conclusions
Perinatal hypoxic ischemic injury leads to a high rate of global
myocardial ischemia. Evaluation with serial troponins should be
performed for at least three days, which is supported by multiple
case series. ECG and serial echocardiography are critical diagnostic
tools in the care of infants with evidence of myocardial injury after
perinatal asphyxia. While extreme elevation of serum cardiac en-
zymes may suggest irreversible injury and high risk of mortality,
many patients with high serum cardiac enzymes survive to
discharge following ECMO support. We suggest that ECMO support
is warranted in patients with refractory cardiorespiratory failure in
the setting of myocardial ischemia and high troponins; however,
more data is needed to elucidate the predictive value of cardiac
biomarkers in patients that may beneﬁt from ECMO.
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